胸腔镜胸交感神经干切断术治疗手汗症66例临床分析

目的：探讨胸腔镜胸交感神经干切断术治疗手汗症的效果。方法：全麻，支气管双腔插管及在胸腔镜下完成66例(130侧)胸交感神经干切断术，平均手术时间55min。结果：完成交感神经干切断术的同侧手掌出汗异常增多现象消失。结论：胸腔镜胸交感神经干切断术是治疗手汗症安全有效的方法。     

胸腔镜下胸交感神经干切断术治疗手汗症15例

目的：评价胸腔镜下双侧T2-T4胸交感神经干切断术治疗手汗症的效果。方法：应用两孔法胸腔镜下胸交感神经干切断治疗手汗症。结果：15例手汗症均治愈，随访2周-12个月，术后2周内出现胸背部疼痛2例。口服布洛芬可缓解；1例出现胸背部代偿性出汗，基本可以忍受。所有患者对手术结果均表示满意。结论：胸腔镜下胸交感神经干切断术治疗手汗症创伤小，手术安全，疗效确切。     

电视胸腔镜胸交感神经干切断术治疗手汗症临床应用研究

目的探讨电视胸腔镜胸交感神经干切断术治疗手汗症的安全性和有效性。方法 18例手汗症患者在双腔气管插管全麻下接受胸腔镜下双侧胸T3~T4交感神经干切断术,术中采用红外线测温仪监测手掌温度的变化。结果全组手术顺利,无手术死亡。术中监测交感神经干切断前后手掌温度平均升高(2.5±0.7)℃,术毕患者手掌多汗症状消失,双手转为干燥温暖,平均手术时间(60.5±25.7)min、术后平均住院(1.9±0.6)d,所有患者术后随访3~24个月,平均(12.7±5.3)个月,无一例复发。结论胸腔镜交感神经干切断术是治疗手汗症安全、微创和有效的方法。     

胸腔镜下T4胸交感神经干加旁路纤维切断术治疗原发性手汗症

目的:观察胸腔镜下T4胸交感神经干加旁路纤维切断术治疗原发性手汗症的临床疗效并总结临床经验。方法:回顾性分析中南大学湘雅二医院2008年10月至2011年6月胸腔镜辅助下改良胸交感神经干T4切断术治疗手汗症32例的临床资料。结果:32例手术均获成功,术后患者手掌多汗症状消失,双手由湿冷转为干燥温暖,术后掌温升高(1.9±0.6)℃。所有患者术后随访1~38个月,平均16个月,无1例复发。结论:胸腔镜下T4交感神经干加旁路纤维切断术是治疗原发性手汗症安全、微创和有效的方法。     

胸腔镜下胸交感神经干切断术治疗手汗症15例

目的:评价胸腔镜下双侧T2～T4胸交感神经干切断术治疗手汗症的效果。方法:应用两孔法胸腔镜下胸交感神经干切断治疗手汗症。结果:15例手汗症均治愈,随访2周～12个月,术后2周内出现胸背部疼痛2例,口服布洛芬可缓解;1例出现胸背部代偿性出汗,基本可以忍受。所有患者对手术结果均表示满意。结论:胸腔镜下胸交感神经干切断术治疗手汗症创伤小,手术安全,疗效确切。     

胸腔镜胸交感神经干切断术治疗手汗症46例疗效探讨

目的 总结胸腔镜胸交感神经干切断术治疗手汗症的经验.方法 1996年8月～2003年12月,全麻、支气管双腔插管下完成胸腔镜胸交感神经干切断术46例,术中采用电凝毁损双侧第二交感神经节.结果 39例术后手汗立即消失,5例手汗减少,2例一侧失败,3例一侧复发.结论 胸腔镜胸交感神经干切断术是治疗手汗症的有效的微创治疗手段,其手术技巧和解剖定位是治疗效果的关键.     

胸腔镜下胸交感神经切断术治疗手汗症的研究

目的:探讨胸腔镜胸交感神经切断术治疗手汗症的安全性和有效性.方法:对16例手汗症患者采用双腔气管插管全麻,电视胸腔镜下依次切断双侧胸3交感神经节手术治疗.结果:全组病例手术均获成功.所有患者术毕手掌多汗的症状即消失,皮温升高,双侧手术时间平均21 min.术后平均住院时间为2.2 d,术后无气胸、代偿性多汗及Homer's综合症等并发症.随访1～12个月,平均5.9个月,手汗症状无一例复发.结论:胸腔镜下胸3交感神经节切除术治疗手汗症,疗效确切,创伤小,恢复快,并发症少.     

改良胸腔镜下胸交感神经链切断术治疗手汗症41例

目的探讨改良胸腔镜下胸交感神经链切断术治疗手汗症的可行性和有效性。方法 41例手汗症患者采用单腔气管插管全麻半坐位于电视胸腔镜监视下行T3或T3～4胸交感神经干切断术治疗手汗症。结果 41例手术均获成功。所有患者术后手汗症状均消失,合并腋窝与足底多汗者,症状亦明显缓解。全组平均手术时间(42±12)min,平均住院时间(2.5±1.6)d。术后无血胸、霍纳综合征等严重并发症发生。25例术后出现轻至中度代偿性多汗,但症状均于6个月内消失。术后随访1年,症状无复发。结论改良胸腔镜下胸交感神经链切断术治疗手汗症,安全可靠,术后并发症少。     

胸腔镜胸交感神经切断术治疗手汗症

目的 通过胸腔镜胸交感神经切断术观察该方法治疗手汗症的效果.方法 对18例手汗症患者在电视胸腔镜下行胸2、3交感神经切断术.结果 18例患者痊愈出院,术后手汗症状均消失,手掌温度上升1.5～3.0℃.住院3～7天,平均4.6天.全组无切口感染及霍纳征等并发症发生.结论 胸腔镜胸交感神经切断术,是治疗手汗症的一种简单、安全、有效的方法.     

电视胸腔镜胸交感神经干切断术治疗手汗症10例报告

目的总结电视胸腔镜外科技术治疗手汗症的经验。方法应用电视胸腔镜手术（VATS）行双侧胸交感神经干切断术治疗手汗症10例。VATS两孔腋下径路,用钩状电刀切断T3～T4交感神经干;双侧手术可在同一体位完成。结果无中转开胸。术后双手立即干燥、红润,所有患者手汗和腋汗全部消失,无手术死亡和严重并发症。结论VATS胸交感神经干切断术能精确显露胸交感神经链,解剖定位准确,创伤小,安全可靠,术后恢复快,疗效确实。     

32例电视胸腔镜胸交感神经干切除术治疗手汗症报道

目的总结电视胸腔镜下胸交感神经切除术治疗手汗症的临床经验。方法分析2004年3月~2006年12月间,应用电视胸腔镜行选择性胸交感神经干切除术治疗32例手汗症患者的临床资料,并对该手术进行文献复习和讨论。结果32例患者手术全部成功。平均手术时间(双侧)42min(28~76min),平均住院时间4.8d。平均随访时间22.5个月(10~41个月),17例(53.1%)患者出现躯干、大腿和脚等处的代偿性多汗,但患者能够耐受,不需要进一步治疗。结论电视胸腔镜下选择性胸交感神经干切除术是治疗手汗症的一种疗效确切、创伤小和安全的治疗方法。     

胸腔镜下胸交感神经链切断术治疗手汗症

目的探讨胸腔镜下胸交感神经链切断术治疗手汗症的疗效和安全性。方法45例手汗症患者全身麻醉后在胸腔镜下行双侧胸3～4交感神经链切断术,术中持续监测心电图、平均动脉压、脉搏血氧饱和度、呼气末二氧化碳浓度及双手温度。手术前、后24 h行动态心电图检查。随访症状缓解情况、代偿性出汗和满意程度,评估手术前、后焦虑水平及其对日常生活的影响程度。结果平均手术时间为(35.6±5.7)min,术中血流动力学稳定。术后手掌多汗症状均消失,双手掌皮肤温度均较术前显著升高(P值均<0.01)。并发气胸及皮下气肿2例,无严重并发症。手术前、后24 h平均心率及矫正的QT间期比较差异均无统计学意义(P>0.05)。41例患者术后随访6～36个月,无复发。代偿性出汗18例(43.9%),其中轻度出汗16例(39.0%),中度出汗2例(4.9%)。手术后焦虑症状及对日常生活的影响较手术前均明显改善(P值均<0.01)。31例(75.6%)患者对手术非常满意,10例(24.4%)比较满意。结论胸腔镜下胸交感神经链切断术能显著减少双手出汗,提高生活质量,患者对手术满意度高,但应对患者强调常见并发症特别是代偿性出汗的可能。     

电视胸腔镜下的手汗症外科微创治疗

目的探讨胸腔镜下切断胸交感神经链治疗原发性手汗症的有效性与安全性。方法对56例手汗症患者行胸腔镜下胸交感神经链切断术。术中实时监测手掌皮肤温度,以温度变化决定交感神经链的切断范围。结果术后患者手汗症状全部消失(100%),手掌温度上升1.4℃~3.8℃,16例(100%)并腋汗增多者症状全部消失;并足汗增多者40例中,消失30例(75%),减轻10例(25%)。术后有5例出现少量气胸,1例血胸;未出现代偿性多汗及霍纳征等严重术后并发症。结论胸腔镜下切断胸交感神经链治疗原发性手汗症是一种创伤性小、有效率高、安全性好的理想手术方式。     

Uniportal versus biportal video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis

Background Video-assisted thoracoscopic sympathectomy had replaced open surgery. The aim of this study was to compare the outcomes of using a single port and two pods to perform video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis. Methods Between April 2006 and February 2008, 20 cases underwent video-assisted thoracoscopic sympathectomy through one port (uniportal group) and 25 cases through two pods (biportal group). The variables including the operating time, hospital stay, pain scores, postoperative complications, incidence of symptom recurrence and patient satisfaction were compared. The mean postoperative follow-up period was 11.5 months (range, 3-25 months). Results The hands of all patients were warm and dry after operation. No conversion to open surgery was necessary, and no operative mortality was recorded in either group. The mean inpatient pain scores were significantly higher in the biportal group (1.2±0.6) than that in the uniportal group (0.8±0.5, p=0.025). For the first three weeks after operation, four out of 20 (20%) patients in the uniportal group constantly suffered from mild or moderate residual pain while eight out of 25 (32%) cases in the biportal group (P=0.366). Among them, two cases in the uniportal group and five cases in the biportal group need to take analgesics. Our mean operative time (bilateral sympathectomy) in the uniportal group ((39.5±10.0) minutes) was shorter than that in biportal group ((49.7±10.6) minutes, P=0.02). There were no significant differences between two groups in terms of the mean hospital stay, compensatory sweating, and patient satisfaction. Two patients in the biportal group and three in the uniportal group experienced a unilateral pneumothorax. None of them required chest drainage. No patient experienced Homer's syndrome, and no recurrent symptoms were observed in either groupsConclusions Both uniportal and biportal video-assisted thoracoscopic sympathectomy are effective, safe, and minimally invasive for palmar hyperhidrosis. Comparing with the biportal approach, the uniportal approach causes lesspostoperative pain and less operative time, and is a more reasonable procedure in treatment of palmar hyperhidrosis.     

电视纵隔镜与胸腔镜胸交感神经链切断术治疗手汗症的比较

目的 :探讨电视纵隔镜胸交感神经链切断术治疗手汗症的可行性。方法 :气管插管全麻 ,30°～ 4 5°半坐位 ,两臂外展 90°,电视纵隔镜从腋前线第 3肋间小切口置入 ,电钩切断T2～T4交感神经链。结果 :手术时间 2 0～ 4 0min ,平均 30min。单纯手汗合并而部及腋窝多汗均消失 ,双手温度上升0 .8～ 3.0℃ ,温暖而干燥。住院 3～ 30d ,平均 3.5 4d。无严重并发症发生 ,1例气胸需较长时间胸腔引流 ,背部代偿性多汗 34例。结论 :电视纵隔镜胸交感神经链切断术治疗手汗症可行。比常规电视胸腔镜减少 1～ 2个切口 ,操作简单 ,病人易于接受 ,可部分取代电视胸腔镜手术。     

单孔电视胸腔镜下手汗症患者胸交感神经节切断术麻醉管理

目的 观察单肺通气下单孔电视胸腔镜胸交感神经节切断术治疗手汗症的疗效,探讨麻醉管理经验及围术期手温变化的临床意义.方法 全部采取支气管内全凭静脉麻醉,单肺通气,常规监测平均动脉压(MAP)、心率(HR)、脉搏氧饱和度(SpO2)、呼末二氧化碳(PETCO2).分别在神经节切断前,切断后5、10、20、30、60 min监测手温.并记录手术时间、拔管时间和术后并发症.结果 围术期患者生命体征基本平稳,关胸膨肺时MAP、PETCO2显著下降(P<0.01).单肺通气过程中,SpO2有所下降,多能维持良好氧合.16例(89%)患者在切断T3交感神经节后,另2例在追加切断T4交感神经节后5 min,术侧手温都升高1℃以上(P<0.05),30 min后手温升至最高点.结论 支气管内全凭静脉麻醉下单肺通气,能为VATS胸交感神经链切断术创造良好的条件,但应加强呼吸和循环管理,保证手术的成功和患者的安全.     

Uniportal versus biportal video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis

Background Video-assisted thoracoscopic sympathectomy had replaced open surgery. The aim of this study was to compare the outcomes of using a single port and two ports to perform video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis. Methods Between April 2006 and February 2008, 20 cases underwent video-assisted thoracoscopic sympathectomy through one port （uniportal group） and 25 cases through two ports （biportal group）. The variables including the operating time, hospital stay, pain scores, postoperative complications, incidence of symptom recurrence and patient satisfaction were compared. The mean postoperative follow-up period was 11.5 months （range, 3-25 months）. Results The hands of all patients were warm and dry after operation. No conversion to open surgery was necessary, and no operative mortality was recorded in either group. The mean inpatient pain scores were significantly higher in the biportal group （1.2±0.6） than that in the uniportal group （0.8±0.5, P=0.025）. For the first three weeks after operation, four out of 20 （20%） patients in the uniportal group constantly suffered from mild or moderate residual pain while eight out of 25 （32%） cases in the biportal group （P=0.366）. Among them, two cases in the uniportal group and five cases in the biportal group need to take analgesics. Our mean operative time （bilateral sympathectomy） in the uniportal group （（39.5±10.0） minutes） was shorter than that in biportal group （（49.7±10.6） minutes, P=0.02）. There were no significant differences between two groups in terms of the mean hospital stay, compensatory sweating, and patient satisfaction. Two patients in the biportal group and three in the uniportal group experienced a unilateral pneumothorax. None of them required chest drainage. No patient experienced Homer＇s syndrome, and no recurrent symptoms were observed in either groups Conclusions Both uniportal and biportal video-assisted thoracoscopic sympathectomy are effective, safe, and minimally invasive for palmar hyperhidrosis. Comparing with the biportal approach, the uniportal approach causes less postoperative pain and less operative time, and is a more reasonable procedure in treatment of palmar hyperhidrosis.     

Uniportal versus biportal video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis

Background Video-assisted thoracoscopic sympathectomy had replaced open surgery. The aim of this study was to compare the outcomes of using a single port and two pods to perform video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis. Methods Between April 2006 and February 2008, 20 cases underwent video-assisted thoracoscopic sympathectomy through one port (uniportal group) and 25 cases through two pods (biportal group). The variables including the operating time, hospital stay, pain scores, postoperative complications, incidence of symptom recurrence and patient satisfaction were compared. The mean postoperative follow-up period was 11.5 months (range, 3-25 months). Results The hands of all patients were warm and dry after operation. No conversion to open surgery was necessary, and no operative mortality was recorded in either group. The mean inpatient pain scores were significantly higher in the biportal group (1.2±0.6) than that in the uniportal group (0.8±0.5, p=0.025). For the first three weeks after operation, four out of 20 (20%) patients in the uniportal group constantly suffered from mild or moderate residual pain while eight out of 25 (32%) cases in the biportal group (P=0.366). Among them, two cases in the uniportal group and five cases in the biportal group need to take analgesics. Our mean operative time (bilateral sympathectomy) in the uniportal group ((39.5±10.0) minutes) was shorter than that in biportal group ((49.7±10.6) minutes, P=0.02). There were no significant differences between two groups in terms of the mean hospital stay, compensatory sweating, and patient satisfaction. Two patients in the biportal group and three in the uniportal group experienced a unilateral pneumothorax. None of them required chest drainage. No patient experienced Homer's syndrome, and no recurrent symptoms were observed in either groupsConclusions Both uniportal and biportal video-assisted thoracoscopic sympathectomy are effective, safe, and minimally invasive for palmar hyperhidrosis. Comparing with the biportal approach, the uniportal approach causes lesspostoperative pain and less operative time, and is a more reasonable procedure in treatment of palmar hyperhidrosis.     

Uniportal versus biportal video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis

Background Video-assisted thoracoscopic sympathectomy had replaced open surgery. The aim of this study was to compare the outcomes of using a single port and two pods to perform video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis. Methods Between April 2006 and February 2008, 20 cases underwent video-assisted thoracoscopic sympathectomy through one port (uniportal group) and 25 cases through two pods (biportal group). The variables including the operating time, hospital stay, pain scores, postoperative complications, incidence of symptom recurrence and patient satisfaction were compared. The mean postoperative follow-up period was 11.5 months (range, 3-25 months). Results The hands of all patients were warm and dry after operation. No conversion to open surgery was necessary, and no operative mortality was recorded in either group. The mean inpatient pain scores were significantly higher in the biportal group (1.2±0.6) than that in the uniportal group (0.8±0.5, p=0.025). For the first three weeks after operation, four out of 20 (20%) patients in the uniportal group constantly suffered from mild or moderate residual pain while eight out of 25 (32%) cases in the biportal group (P=0.366). Among them, two cases in the uniportal group and five cases in the biportal group need to take analgesics. Our mean operative time (bilateral sympathectomy) in the uniportal group ((39.5±10.0) minutes) was shorter than that in biportal group ((49.7±10.6) minutes, P=0.02). There were no significant differences between two groups in terms of the mean hospital stay, compensatory sweating, and patient satisfaction. Two patients in the biportal group and three in the uniportal group experienced a unilateral pneumothorax. None of them required chest drainage. No patient experienced Homer's syndrome, and no recurrent symptoms were observed in either groupsConclusions Both uniportal and biportal video-assisted thoracoscopic sympathectomy are effective, safe, and minimally invasive for palmar hyperhidrosis. Comparing with the biportal approach, the uniportal approach causes lesspostoperative pain and less operative time, and is a more reasonable procedure in treatment of palmar hyperhidrosis.